Cargando…
R-Propranolol Has Broad-Spectrum Anti-Coronavirus Activity and Suppresses Factors Involved in Pathogenic Angiogenesis
The SARS-CoV-2 pandemic highlighted the need for broad-spectrum antivirals to increase our preparedness. Patients often require treatment by the time that blocking virus replication is less effective. Therefore, therapy should not only aim to inhibit the virus, but also to suppress pathogenic host r...
Autores principales: | Thaler, Melissa, Salgado-Benvindo, Clarisse, Leijs, Anouk, Tas, Ali, Ninaber, Dennis K., Arbiser, Jack L., Snijder, Eric J., van Hemert, Martijn J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003112/ https://www.ncbi.nlm.nih.gov/pubmed/36902020 http://dx.doi.org/10.3390/ijms24054588 |
Ejemplares similares
-
Honokiol Inhibits SARS-CoV-2 Replication in Cell Culture at a Post-Entry Step
por: Salgado-Benvindo, Clarisse, et al.
Publicado: (2023) -
Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle
por: Salgado-Benvindo, Clarisse, et al.
Publicado: (2020) -
Impact of Changes in Human Airway Epithelial Cellular Composition and Differentiation on SARS-CoV-2 Infection Biology
por: Thaler, Melissa, et al.
Publicado: (2023) -
Propranolol exhibits activity against hemangiomas independent of beta blockade
por: Sasaki, Maiko, et al.
Publicado: (2019) -
Combinative effects of β-elemene and propranolol on the proliferation, migration, and angiogenesis of hemangioma
por: Wang, Zhenyu, et al.
Publicado: (2023)